EORTC AISBL / IVZW Avenue Mounierlaan, 83/11 Brussel 1200 Bruxelles • Belgie Belgique +32 2 774 16 11
Intranet • Home

Open studies are marked with a purple background, closed studies have a grey background, studies to be opened have a white background

06023

Randomized phase II trial with infliximab (Remicade (R)) in patients with myelodysplastic syndrome and a relatively low risk of developing acute leukemia.

Back to Protocol section